Navigation Links
Slone Partners Fills VP of Scientific Affairs Role for Cambridge Biomedical

National executive search firm, Slone Partners, announces the placement of Linda Robbie, PhD, a well-versed leader with extensive assay development and biomarker expertise, as VP of Scientific Affairs at Cambridge Biomedical.

Established in 1997, Cambridge Biomedical is a Boston CRO specializing in bio-analytical assay development and sample testing services. The organization acts as a leading provider of customized assays for small and large molecules, biomarkers, and diagnostics.

In her new role, Dr. Robbie will serve as the head of science and innovation and will lead and direct all initiatives related to science and technology, clinical operations, and project management.

“Linda is an exceptional addition to our leadership team. Leveraging her unique people management skills and years of successful technology implementation, she will act as our key scientific point person interfacing with both our clients and internal teams. We are pleased to have worked with Slone Partners on this important search. Linda is truly a remarkable scientist and a perfect cultural fit for our organization,” said Chairwoman and CEO of Cambridge Biomedical, Barbara Osband.

Prior to joining Cambridge Biomedical, Dr. Robbie served as the Global Senior Director of Biomarkers and Translational Science at Q² Solutions Laboratories, a Quintiles-Quest Joint Venture, where she led assay development teams in the U.S. and overseas.

Dr. Robbie earned a Bachelor of Science, with honors, in Biochemistry from Heriot-Watt University in Edinburgh, Scotland, and a PhD, in Immunohematology from the Institute of Medical Science, Aberdeen University, Scotland.

About Slone Partners

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the life sciences, diagnostics, clinical trials, contract research, therapeutics, healthcare information technology, and laboratory testing industries with offices in Boston, Washington, D.C. and San Francisco. Innovative, world-class organizations from across the nation have chosen Slone Partners to fill their key positions. To learn more about Slone Partners’ services, visit:

About Cambridge Biomedical

Cambridge Biomedical, based in Boston, MA, supports sponsors by developing customized assays for small and large molecules, biomarkers and other critical analytes, along with validation and sample testing in CLIA-certified and CAP-accredited, GLP/GCLP-compliant facilities. Cambridge Biomedical has extensive expertise in assay development, optimization and validation, and offers analytical support for PK/PD studies, biomarker development, clinical assay development, assay validation, specimen analysis and testing services. For more information, visit the website at, email info(at)cambridgebiomedical(dot)com or call 617.456.0700.

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. Slone Partners Hosts Precision Medicine Event Led by Michael Pellini, MD with Panelists Troy Cox, Barbara Weber, MD and Roman Yelensky, PhD
2. Slone Partners Pledges its Support as Corporate Benefactor for the 2017 Executive War College
3. Slone Partners Places Chief Executive Officer at La Peer Health Systems
4. Slone Partners Places Chief Executive Officer at Avomeen Analytical Services
5. Slone Partners Designated by Hunt Scanlon Media as one of the “Top 50 Healthcare and Life Science Search Firms”
6. Slone Partners Places President & Chief Commercial Officer at GenePeeks
7. Slone Partners Sponsors the SCOPE Summit for Clinical Ops Executives 2017
8. Slone Partners Fills Head of Sales at Optimal Medicine
9. Executive Search Firm Slone Partners Expands With New San Francisco Office
10. Slone Partners Meets Growing Demand as Industry Focuses on Reimbursement & Regulation
11. Slone Partners CEO & President Speak about Hiring Challenges in Molecular Diagnostics at Executive War College 2013
Post Your Comments:
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... Wayne. NJ (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a ... rinse one eye at a time. So which eye do you rinse first if a ... you have Plum Duo Eye Wash with its unique dual eye piece. , ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... ... ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled a ... new look is part of a transformation to increase awareness, appeal to new markets ... It will also expand its service offering from its signature gourmet cooking classes and ...
Breaking Biology Technology:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
Breaking Biology News(10 mins):